Paul Josephs compensation by year
Lifecore Biomedical Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $10,557 | $550,000 |
| Bonus | $125,000 | $275,000 |
| Stock awards | $10,111,500 | $274,996 |
| Option awards | $0 | — |
| Non-equity incentive | $0 | — |
| Pension and deferred compensation | $0 | — |
| All other | $0 | $15,309 |
| Total | $10,247,057 | $1,115,305 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lifecore Biomedical, Inc. DEF 14A filed April 24, 2026, accession 0001005286-26-000012, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Lifecore Biomedical, Inc. filed document, accession 0001005286-26-000012. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 1,350,000 | $11,043,000 | — |
| RSU | 400,000 | $3,272,000 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Lifecore Biomedical, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments Lifecore Biomedical discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $1,180,000 | $3,272,000 | $25,054 | $5,067,054 |
| Involuntary termination without cause | $1,180,000 | $3,272,000 | $25,054 | $5,081,054 |
Per the Potential Payments Upon Termination or Change in Control table in Lifecore Biomedical, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Lifecore Biomedical’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Ryan Lake | Executive Vice President, Chief Financial Officer | $4,302,439 |
| Thomas Salus | Chief Legal and Administrative Officer | $4,098,554 |
| Paul Josephs · this page | President and Chief Executive Officer | $1,115,305 |
Board service
Lifecore Biomedical board · FY2024–FY2025How this board is paid
Company policy: Lifecore Biomedical pays directors a $50,000 cash retainer and $150,000 in RSUs. As stated in Lifecore Biomedical's FY2025 proxy.
The full Lifecore Biomedical compensation record
free company briefThis page is one person within Lifecore Biomedical's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Lifecore Biomedical proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Lifecore Biomedical's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Lifecore Biomedical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order LFCR
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.